Recruiting
Effects of an ACT-based Psychological Treatment in Patients With Chronic Kidney Disease
Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of patients with chronic kidney disease.
ClinicalTrials.gov IDNCT06109493
PhaseNA
Enrollment104
SponsorUniversidad Europea de Madrid
Age18 Years and older
SexALL
Conditions studied
Chronic Kidney Diseases, Depression
About this study
Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of patients with chronic kidney disease.
Interventions
- Behavioral: ACT — Acceptance and Commitment Therapy methods were focused on promoting Values clarification, Acceptance, Cognitive defusion, Committed action and Flexible attention to the present moment, and included methods such as the Garden Metaphor, Funeral exercise or Mindfulness training.
Primary outcomes
- Change in emotional distress assessed through Hospital Anxiety and Depression Scale (HADS) (Change from Baseline Emotional Distress at 5 months)
Eligibility information
Inclusion Criteria:
* Patients with chronic kidney disease on haemodialysis
* Older than 18 years-old
* At least 3 months on haemodialysis
* HADS Global Scale Score ≥14
Exclusion Criteria:
* Diagnosis of severe or chronic mental disorder, mental retardation and cognitive impairment, or disabling illness.
* Antidepressant drugs consume
* Insufficient understanding of Spanish.
* Patients who are in the Advanced Chronic Kidney Disease Unit
* Receiving other psychological treatment
Study locations
- Fundación Renal Iñigo Alvarez de Toledo, Madrid, 28003 Spain
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-20.